ADAP stock price (quote)
$1.14 -6.56% Thursday, 5th Dec 2019
Close price at the end of the last trading day (Thursday, 5th Dec 2019) of the ADAP stock was $1.14. This is 6.56% less than the trading day before Wednesday, 4th Dec 2019.
During the day the stock fluctuated 13.89% from a day low at $1.08 to a day high of $1.23.
Quick summary:
- 30 day high of the ADAP stock price was $1.29 and low was $0.71.
- 90 day high was $2.25 and low was $0.71.
- 52 week high for Adaptimmune Therapeutics plc - $6.31 and low - $0.71.
VOLUME
Buy
TREND
Sell
MV LONG
Buy
MV SHORT
Buy
PIVOT
Sell
MACD
Buy
Historical Adaptimmune Therapeutics plc prices
| Date | Open | High | Low | Close | Volume |
| 2019-09-25 | $1.56 | $1.71 | $1.55 | $1.67 | 137383 |
| 2019-09-24 | $1.65 | $1.65 | $1.53 | $1.59 | 103593 |
| 2019-09-23 | $1.75 | $1.78 | $1.61 | $1.65 | 266518 |
| 2019-09-20 | $1.77 | $1.78 | $1.69 | $1.77 | 187716 |
| 2019-09-19 | $1.78 | $1.78 | $1.68 | $1.75 | 144932 |
| 2019-09-18 | $1.77 | $1.78 | $1.71 | $1.75 | 95645 |
| 2019-09-17 | $1.80 | $1.82 | $1.70 | $1.80 | 135671 |
| 2019-09-16 | $1.84 | $1.86 | $1.75 | $1.80 | 132595 |
| 2019-09-13 | $1.92 | $1.97 | $1.81 | $1.84 | 151230 |
| 2019-09-12 | $1.92 | $1.95 | $1.82 | $1.93 | 152223 |
| 2019-09-11 | $2.19 | $2.25 | $1.91 | $1.94 | 397600 |
| 2019-09-10 | $1.71 | $2.14 | $1.71 | $2.11 | 626539 |
| 2019-09-09 | $1.56 | $1.76 | $1.56 | $1.70 | 179717 |
| 2019-09-06 | $1.65 | $1.68 | $1.54 | $1.57 | 401959 |
| 2019-09-05 | $1.68 | $1.80 | $1.62 | $1.66 | 214112 |
| 2019-09-04 | $1.59 | $1.66 | $1.55 | $1.65 | 395428 |
| 2019-09-03 | $1.60 | $1.64 | $1.51 | $1.56 | 298735 |
| 2019-08-30 | $1.61 | $1.68 | $1.53 | $1.61 | 270906 |
| 2019-08-29 | $1.62 | $1.65 | $1.54 | $1.60 | 115060 |
| 2019-08-28 | $1.54 | $1.67 | $1.52 | $1.60 | 178849 |
| 2019-08-27 | $1.48 | $1.58 | $1.37 | $1.53 | 446225 |
| 2019-08-26 | $1.47 | $1.60 | $1.41 | $1.43 | 177172 |
| 2019-08-23 | $1.44 | $1.55 | $1.40 | $1.43 | 290889 |
| 2019-08-22 | $1.60 | $1.69 | $1.44 | $1.44 | 279036 |
| 2019-08-21 | $1.62 | $1.66 | $1.55 | $1.58 | 549674 |
| 2019-08-20 | $1.75 | $1.82 | $1.62 | $1.62 | 159294 |
| 2019-08-19 | $1.68 | $1.80 | $1.65 | $1.75 | 186296 |
| 2019-08-16 | $1.45 | $1.78 | $1.44 | $1.63 | 322424 |
| 2019-08-15 | $1.51 | $1.61 | $1.45 | $1.46 | 331223 |
| 2019-08-14 | $1.70 | $1.72 | $1.51 | $1.52 | 359278 |
| 2019-08-13 | $1.73 | $1.77 | $1.70 | $1.75 | 237516 |
| 2019-08-12 | $1.90 | $1.96 | $1.61 | $1.71 | 536865 |
| 2019-08-09 | $1.98 | $2.00 | $1.85 | $1.94 | 340961 |
| 2019-08-08 | $2.02 | $2.10 | $1.97 | $1.98 | 384504 |
| 2019-08-07 | $2.05 | $2.05 | $1.98 | $2.03 | 328086 |
| 2019-08-06 | $2.25 | $2.32 | $1.90 | $2.11 | 775080 |
| 2019-08-05 | $2.51 | $2.56 | $2.07 | $2.20 | 822390 |
| 2019-08-02 | $2.87 | $2.87 | $2.26 | $2.51 | 1834683 |
| 2019-08-01 | $3.49 | $3.49 | $2.85 | $2.95 | 481200 |
| 2019-07-31 | $3.26 | $3.40 | $3.21 | $3.29 | 190685 |
| 2019-07-30 | $3.13 | $3.33 | $3.04 | $3.28 | 167731 |
| 2019-07-29 | $3.18 | $3.28 | $3.07 | $3.12 | 89621 |
| 2019-07-26 | $3.01 | $3.20 | $2.94 | $3.18 | 239323 |
| 2019-07-25 | $3.32 | $3.32 | $3.00 | $3.01 | 527846 |
| 2019-07-24 | $3.49 | $3.49 | $3.30 | $3.31 | 226163 |
| 2019-07-23 | $3.73 | $3.79 | $3.45 | $3.49 | 174868 |
| 2019-07-22 | $3.31 | $3.84 | $3.20 | $3.65 | 541505 |
| 2019-07-19 | $3.45 | $3.47 | $3.24 | $3.27 | 183338 |
| 2019-07-18 | $3.39 | $3.45 | $3.35 | $3.44 | 142246 |
| 2019-07-17 | $3.46 | $3.47 | $3.33 | $3.35 | 199781 |
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Latest ADAP News
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
12:08pm, Friday, 15'th Nov 2019
Cowen Reaffirms “Buy” Rating for Adaptimmune Therapeutics (NASDAQ:ADAP)
11:15pm, Monday, 11'th Nov 2019
Is Adaptimmune Therapeutics plc (ADAP) Is Burning These Hedge Funds
05:52pm, Thursday, 31'st Oct 2019
The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug
11:12am, Friday, 25'th Oct 2019
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
11:58am, Wednesday, 09'th Oct 2019
The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
11:32am, Friday, 04'th Oct 2019
Adaptimmune (ADAP) Gets Orphan Drug Status for T-cell Therapy
08:01am, Tuesday, 10'th Sep 2019Proudly made at
